Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Simpson

Showing results (101-110 of 105) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 105 results.
Histopathology|February 15, 2000
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomasH Gobbi, C L Arteaga, R A Jensen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
Uterine effects of tamoxifen: a prospective studyK F McGonigle, D D Smith, H F Marx, et al.
Nature Medicine|December 1, 1995
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesionsD Weinstat-Saslow, M J Merino, R E Manrow, et al.
British Journal of Cancer|August 15, 2002
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancerG Somlo, J F Simpson, P Frankel, et al.
Archives of Pathology & Laboratory Medicine|July 11, 2000
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999P L Fitzgibbons, D L Page, D Weaver, et al.
Pageof 11

Showing results (101-110 of 105) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 105 results.
Histopathology|February 15, 2000
Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomasH Gobbi, C L Arteaga, R A Jensen, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 10, 2006
Uterine effects of tamoxifen: a prospective studyK F McGonigle, D D Smith, H F Marx, et al.
Nature Medicine|December 1, 1995
Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesionsD Weinstat-Saslow, M J Merino, R E Manrow, et al.
British Journal of Cancer|August 15, 2002
Predictors of long-term outcome following high-dose chemotherapy in high-risk primary breast cancerG Somlo, J F Simpson, P Frankel, et al.
Archives of Pathology & Laboratory Medicine|July 11, 2000
Prognostic factors in breast cancer. College of American Pathologists Consensus Statement 1999P L Fitzgibbons, D L Page, D Weaver, et al.
Pageof 11